Page References

1. Chang JY, Komaki R, Lu C, et al. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer. 2011;117(20):4707-4713.

2. Sejpal S, Komaki R, Tsao A, et al. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for non-small-cell lung cancer. Cancer. 2011;117:3004-3013.

FAQ References

3. Chang JY, Zhang X, Wang X, et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in stage I or stage III non–small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;65(4):1087-1096.

4. Chang JY, Komaki R, Lu C, et al. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer. 2011;117(20):4707-4713.

5. Sejpal S, Komaki R, Tsao A, et al. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer. Cancer. 2011;117(13):3004-3013.

6. Chang JY, Komaki R, Lu C, et al. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer. 2011;117:4707-4713.

7. Chang JY, Komaki R, Lu C, et al. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer. 2011;117(20):4707-4713.

8. Sejpal S, Komaki R, Tsao A, et al. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer. Cancer 2011;117(13):3004-3013.

Facts References

9. American Cancer Society. About Non-Small Cell Lung Cancer. Atlanta, GA: American Cancer Society; 2018.

10. American Cancer Society. Non-Small Cell Lung Cancer Signs and Symptoms. Atlanta, GA: American Cancer Society; 2016

11. American Cancer Society. Non-Small Cell Lung Cancer Causes, Risk Factors, and Prevention. Atlanta, GA: American Cancer Society; 2016

12. American Cancer Society. Non-Small Cell Lung Cancer Early Detection, Diagnosis, and Staging. Atlanta, GA: American Cancer Society; 2016.